What is Ipsen known for?
Improving lives and health outcomes. Ipsen’s vision is to be a leading global mid-size biopharmaceutical company, with a focus on transformative medicines in three key therapeutic areas: oncology, rare disease and neuroscience.
What do ipsen make?
Ipsen is a global, mid-sized biopharmaceutical company focused on transformative medicines in oncology, rare disease and neuroscience.
Where is Ipsen located?
Paris, France
Ipsen is a French pharmaceutical company headquartered in Paris, France. It is specialized in oncology, neuroscience and rare diseases. It is publicly traded on the Euronext Paris as part of the SBF 120 index (2005).
Where is Ipsen Pharma located?
Cambridge, Massachusetts
Global Biopharmaceutical Company, Ipsen Announces New Headquarters for North America will be located in Cambridge, Massachusetts.
How many employees does Ipsen have?
Ipsen, Inc. has 191 total employees across all of its locations and generates $72.90 million in sales (USD).
Is Ipsen a good company?
IPSEN Reviews FAQs Is IPSEN a good company to work for? IPSEN has an overall rating of 4.0 out of 5, based on over 652 reviews left anonymously by employees. 84% of employees would recommend working at IPSEN to a friend and 72% have a positive outlook for the business.
What is it like to work at Ipsen?
People have been very friendly and supportive within Ipsen. Onboarding process was quite disjointed. Ipsen have multiple SOPs, Training and systems and it would have been good to have some immediate assistance with navigating “Ipsen”. IT set-up was good and support was excellent.
Is Ipsen a good place to work?
Not a good place to work anymore The people, diverse work, patient focus. Poor salary, bonus and benefits package compared to similar Pharma companies. Not enough staff. High staff turnover.
Why did Ipsen partner with Inspiration Biopharmaceuticals?
Ipsen and Inspiration Biopharmaceuticals Inc. enter into a partnership to create a hemophilia franchise. Ipsen increases its presence in oncology and endocrinology in South-East Asia through a commercialization agreement with Invida.
Who is Ipsen executive vice president Dominique BERy?
Dominique Bery joined Ipsen in April 2017 as Executive Vice President, Strategy & Transformation. Dominique spent the previous 18 years with McKinsey & Company, where she was elected Partner in 2010.
Who is the head of research and development at Ipsen?
Howard Mayer, M.D. joined Ipsen in December 2019 as Executive Vice President, Head of Research and Development. Howard joined Ipsen from Shire, where he was Chief Medical Officer, responsible for the hematology, immunology, oncology, genetic diseases, GI/metabolic, neuroscience and ophthalmology therapeutic areas.
Who is Ipsen consumer health?
Consumer HealthCare. Ipsen’s long-standing expertise spans the value chain, with special expertise in gastrointestinal (GI) disorders, neurodegenerative pathologies and rheumatology, as well as a constantly expanding portfolio.